Showing results (231-240 of 363) with videos related to
Sort By:
Pageof 37
Urologic Oncology|November 13, 2017
Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the futureTom J N Hermans, Charlotte S Voskuilen, Michiel S van der Heijden, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 28, 2017
Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborativeRahul K Bansal, Simon Tanguay, Antonio Finelli, et al.European Urology Oncology|May 19, 2019
Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative ReviewYair Lotan, Peter C Black, Laura Caba, et al.Urologic Oncology|March 13, 2024
Alignment of molecular subtypes across multiple bladder cancer subtyping classifiersMoritz J Reike, Joep J de Jong, Tarek A Bismar, et al.Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.Nature Reviews. Urology|June 16, 2021
100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19Niyati Lobo, Nathan A Brooks, Alexandre R Zlotta, et al.Glycobiology|April 28, 2020
An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancerAlejandro Gómez Toledo, Jessica Pihl, Charlotte B Spliid, et al.European Urology|March 31, 2021
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant PembrolizumabAndrea Necchi, Joep J de Jong, Daniele Raggi, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 10, 2025
A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, CanadaGeoffrey Gotto, Nimira S Alimohamed, Girish S Kulkarni, et al.Journal of Oncology Practice|August 15, 2013
Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinomaLori Wood, Georg A Bjarnason, Peter C Black, et al.Pageof 37